AI has created a 21st-century hyperabundance of potential new drugs and biological hypotheses, but we are still using 18th-century style animal testing.
Instead,
@Vivodyne is evaluating drugs in living human tissues at industrial scale.
Excited to continue working with Vivodyne as they iterate on their 'Virtual Human' data center, where we can predict treatment response.